Effects of ALO 2145 on intraocular pressure following argon laser trabeculoplasty

A. L. Robin, I. P. Pollack, B. House and C. Enger

A prospective, randomized, double-masked study compared topical 1% ALO 2145, an alpha 2-agonist, with placebo in therapy for immediate postoperative intraocular pressure (IOP) rise after argon laser trabeculoplasty. Seventy-three eyes (73 patients) underwent 360 degrees of treatment utilizing 80 spots of 800 to 1000 mW of power. Intraocular pressure rise was measured hourly for the first three hours after operation, at one week, and at one month. Eyes treated with ALO 2145 had both significantly lower mean IOPs and greater IOP decreases from baseline than placebo-treated eyes during the first three hours after operation. No eyes treated with ALO 2145 and six eyes (18%) treated with placebo experienced an IOP rise of 10 mm Hg or greater. Twenty eyes (59%) in the placebo group and eight eyes (21%) treated with ALO 2145 had an IOP elevation. No change was detected in the mean heart rate. ALO 2145 appears to be effective in eliminating large, acute IOP elevations after argon laser trabeculoplasty.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The sensitivity and specificity of 0.5% apraclonidine in the diagnosis of oculosympathetic paresis
Koc et al.
Br. J. Ophthalmol. 2005;89:1442-1444.
ABSTRACT | FULL TEXT  

Potent {alpha}2A-Adrenoceptor-Mediated Vasoconstriction by Brimonidine in Porcine Ciliary Arteries
Wikberg-Matsson and Simonsen
IOVS 2001;42:2049-2055.
ABSTRACT | FULL TEXT  

Aqueous Humor Flow in Normal Human Eyes Treated With Brimonidine and Timolol, Alone and in Combination
Larsson
Arch Ophthalmol 2001;119:492-495.
ABSTRACT | FULL TEXT  

Effectiveness of apraclonidine 1% in preventing intraocular pressure rise following macular hole surgery
Sciscio and Casswell
Br. J. Ophthalmol. 2001;85:164-168.
ABSTRACT | FULL TEXT  

Comparison of the Efficacy of Apraclonidine and Brimonidine as Aqueous Suppressants in Humans
Schadlu et al.
Arch Ophthalmol 1998;116:1441-1444.
ABSTRACT | FULL TEXT  

Medical Management of Glaucoma
Alward
NEJM 1998;339:1298-1307.
FULL TEXT  

Initial Treatment for Open-Angle Glaucoma--Medical, Laser, or Surgical?: Laser Trabeculoplasty Is the Treatment of Choice for Chronic Open-Angle Glaucoma
Jampel
Arch Ophthalmol 1998;116:240-241.
FULL TEXT  

Open-Angle Glaucoma
Quigley
NEJM 1993;328:1097-1106.
FULL TEXT